Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Trial of CM-AT in Children With Autism- Open Label Extension Study

ClinicalTrials.gov ID: NCT00912691

Public ClinicalTrials.gov record NCT00912691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 7:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open Label Extension Study of CM-AT in Children With Autism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether CM-AT is effective in treating the core symptoms of autism.

Study identification

NCT ID
NCT00912691
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Curemark
Industry
Enrollment
165 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Actual)
Primary completion
Feb 2016 (Actual)
Completion
Feb 2016 (Actual)
Last update posted
Mar 1, 2019

2010 – 2016

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Southwest Autism Research and Resource Center Phoenix Arizona 85006 —
University of California, Davis, M.I.N.D. Institute Sacramento California 95817 —
University of California, San Francisco San Francisco California 94143 —
Neuropsychiatric Research Center of Orange County Santa Ana California 92701 —
Lake Mary Pediatrics Orange City Florida 32763 —
Institute for Behavioral Medicine Smyrna Georgia 30080 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Louisiana State University Shreveport Louisiana 71103 —
Saint Peter's University Hospital New Brunswick New Jersey 08901 —
Mount Sinai School of Medicine Manhattan New York 10029 —
University of North Carolina, Chapel Hill Chapel Hill North Carolina 27514 —
Ohio State University Columbus Ohio 43210 —
Oklahoma State University, Child Study Center Oklahoma City Oklahoma 73117 —
Cyn3rgy Research Center Gresham Oregon 97030 —
Hershey Medical Center Hershey Pennsylvania 17033 —
Drexel University Philadelphia Pennsylvania 19124 —
Universtiy of Pittsburgh Pittsburgh Pennsylvania 15260 —
University of Texas, Houston Houston Texas 77054 —
Ericksen Research & Development Clinton Utah 84015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00912691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 1, 2019 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00912691 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →